| CYPHERPUNK TECHNOLOGIES |
| USA |
| Gesundheit |
| US52187K2006 / A3EMJP |
| 5MC (Frankfurt) / CYPH (NASDAQ) |
| FRA:5MC, ETR:5MC, 5MC:GR, NASDAQ:CYPH |
| - |
| https://www.leaptx.com/ |
|
Cypherpunk Technologies Inc. is a biopharmaceutical company focused on developing novel antibody therapies for cancer treatment, with a strategic emphasis on biomarker-targeted approaches. The company..
>Volltext.. |
| 34.6 Mio. EUR |
| 22.72 Mio. EUR |
| - |
| -31.66 Mio. EUR |
| 4.18 Mio. EUR |
| 0.06 EUR |
| 0.03 Mio. EUR |
| 12.16 Mio. EUR |
| -38.04 Mio. EUR |
| 3.08 |
| - |
| - |
| - |
| - |
| - |
| - |
| CYPHERPUNK, LEAP THERAPEUTICS |
| 19.03.26 |
|